Can hepatitis C be eliminated in the United States by 2030?
- The National Academies of Sciences, Engineering and Medicine released a report about the burden of hepatitis C on public health and gave suggestions for eradicating the disease from the U.S. population by 2030.
- Hepatitis C kills thousands of people each year in the U.S., and can now be quickly cured through innovative, but costly medicines. The committee’s report predicts that treating everyone with chronic hepatitis C could cut new infections by 90% and reduce liver cancer deaths by 65% by 2030.
- To improve access to expensive, potentially-curative drugs, the committee suggested voluntary licensing agreements between the government and pharmaceutical companies for underserved patient populations, leaving companies free to continue to sell the drugs to the wider community.
Read full article: Should the US government license hep C drugs? | BioPharma Dive